Led by San Diego-based Corporate partner Christian Salaman, Pillsbury represented leading urinary health brand Uqora, in its acquisition by Pharmavite, the makers of Nature Made® vitamins and supplements.

Pharmavite provides Uqora with the reach and ability to make products available to everyone who needs them. With the closing of this deal, Pharmavite now offers an unrivaled set of solutions in the women's health space. 

San Diego-based Uqora is the direct-to-consumer leader in urinary health, selling innovative urinary tract supplements and UTI relief products. Uqora’s empathy-first and education-providing approach has led to highly satisfied customers and industry-leading DTC metrics. The company has experienced triple-digit growth since its initial launch in 2017.

Read more here.

In addition to Salaman, the Pillsbury team was led by business consultant Thomas Tiop and included Corporate partner Jason Stirling, Executive Compensation & Benefits partner Mark Jones, Tax senior counsel Laura Watts, Employment Law senior counsel Laura Latham, Executive Compensation & Benefits  associate Ena Kaur, Corporate associate Ryan Minarovich and consulting manager Martin Bridges.

Across decades of experience, Pillsbury has represented startup and emerging company consumer product good (CPG) clients such as Sand Cloud and investors such as HCAP on everything from formation to financing, corporate governance, technology transactions, acquisitions and public offerings. Read more here.